Pyrroles
This graph shows the total number of publications written about "Pyrroles" by people in the URMC Research Network by year, and whether "Pyrroles" was a major or minor topic of these publication.
Below are the most recent publications written about "Pyrroles" by people in Profiles.
-
Zhu AX, Sahani DV, Duda DG, di Tomaso E, Ancukiewicz M, Catalano OA, Sindhwani V, Blaszkowsky LS, Yoon SS, Lahdenranta J, Bhargava P, Meyerhardt J, Clark JW, Kwak EL, Hezel AF, Miksad R, Abrams TA, Enzinger PC, Fuchs CS, Ryan DP, Jain RK. Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J Clin Oncol. 2009 Jun 20; 27(18):3027-35.
-
Spitale RC, Torelli AT, Krucinska J, Bandarian V, Wedekind JE. The structural basis for recognition of the PreQ0 metabolite by an unusually small riboswitch aptamer domain. J Biol Chem. 2009 Apr 24; 284(17):11012-6.
-
Hoeger KM. Polycystic ovary syndrome, inflammation, and statins: do we have the right target? J Clin Endocrinol Metab. 2009 Jan; 94(1):35-7.
-
Samuelson RM, Levy EI, Siddiqui AH, Hopkins LN. The cost of stroke prevention. Stroke. 2009 Feb; 40(2):e41-2; author reply e43.
-
Pearson T, Ballantyne C, Sisk C, Shah A, Veltri E, Maccubbin D. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels. Am J Cardiol. 2007 Jun 15; 99(12):1706-1713.
-
Zareba G. Torcetrapib and atorvastatin: a novel combination therapy for dyslipidemia. Drugs Today (Barc). 2006 Feb; 42(2):95-102.
-
Mi Z, Hong B, Mirnics ZK, Tyurina YY, Kagan VE, Liang Y, Schor NF. Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2. Cancer Chemother Pharmacol. 2006 Feb; 57(3):357-67.
-
Pearson TA, Denke MA, McBride PE, Battisti WP, Brady WE, Palmisano J. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. Mayo Clin Proc. 2005 May; 80(5):587-95.
-
Singh S, Nautiyal A, Dolan JG. Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect? JOP. 2004 Nov; 5(6):502-4.
-
Singh S, Shrivastava R, Das V. Formulary conversion programs: the need for patient-specific risk assessment. MedGenMed. 2004; 6(3):28.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
